4//SEC Filing
Smith Robin L 4
Accession 0001209191-21-054841
CIK 0000850261other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:36 PM ET
Size
11.0 KB
Accession
0001209191-21-054841
Insider Transaction Report
Form 4
Smith Robin L
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-03$4.89/sh+100,000$489,000→ 235,000 total - Exercise/Conversion
Stock Options
2021-09-03−75,000→ 0 totalExercise: $3.95Exp: 2029-12-16→ Common Stock (75,000 underlying) - Exercise/Conversion
Common Stock
2021-09-03$3.95/sh+75,000$296,250→ 135,000 total - Exercise/Conversion
Stock Options
2021-09-03−100,000→ 0 totalExercise: $4.89Exp: 2030-06-15→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]1/12 of the original number of shares subject to this option vested and became exercisable on January 16, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.
- [F2]1/12 of the original number of shares subject to this option vested and became exercisable on July 15, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001365035
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:36 PM ET
- Size
- 11.0 KB